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Background: ADHD and alcoholism are psychiatric diseases with pathophysiology related to dopamine system.
DAT1 belongs to the SLC6 family of transporters and is involved in the regulation of extracellular dopamine levels.
A 40 bp variable number tandem repeat (VNTR) polymorphism in the 3′-untranslated region of DAT1/SLC6A3 gene
was previously reported to be associated with various phenotypes involving disturbed regulation of dopaminergic
neurotransmission.
Methods: A total of 1312 subjects were included and genotyped for 40 bp VNTR polymorphism of DAT1/SLC6A3 gene
in this study (441 alcoholics, 400 non-alcoholic controls, 218 ADHD children and 253 non ADHD children). Using miRBase
software, we have performed a computer analysis of VNTR part of DAT1 gene for presence of miRNA binding sites.
Results: We have found significant relationships between ADHD and the 40 bp VNTR polymorphisms of DAT1/SLC6A3
gene (P < 0.01). The 9/9 genotype appeared to reduce the risk of ADHD about 0.4-fold (p < 0.04). We also noted an
occurrence of rare genotypes in ADHD (frequency different from controls at p < 0.01). No association between
alcoholism and genotype frequencies of 40 bp VNTR polymorphism of DAT1/SLC6A3 gene has been detected.
Conclusions: We have found an association between 40 bp VNTR polymorphism of DAT1/SLC6A3 gene and ADHD in
the Czech population; in a broad agreement with studies in other population samples. Furthermore, we detected rare
genotypes 8/10, 7/10 and 10/11 present in ADHD boys only and identified miRNAs that should be looked at as
potential novel targets in the research on ADHD.
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Dopamine and dopaminergic signalling have been impli-
cated in aetiologies of several psychiatric and neuro-
logical disorders including attention-deficit/hyperactivity
disorder (ADHD) and alcoholism. Dopamine transporter
DAT1 is thought to be the main regulator of synaptic
and extracellular levels of dopamine and, consequently,
the corresponding gene DAT1/SLC6A3, has been among* Correspondence: omarsery@sci.muni.cz
1Laboratory of Neurobiology and Molecular Psychiatry, Department of
Biochemistry, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno,
Czech Republic
2Institute of Animal Physiology and Genetics, Academy of Science, Veveří 97,
602 00 Brno, Czech Republic
Full list of author information is available at the end of the article
© 2015 Šerý et al. This is an Open Access artic
(http://creativecommons.org/licenses/by/4.0),
provided the original work is properly credited
creativecommons.org/publicdomain/zero/1.0/the most often studied candidate genes in relation to
ADHD [1]. This is perhaps less so in the case of alco-
holism [2, 3].
DAT1 is a Na+ and Cl− dependent transporter of the
solute carrier family 6 (SLC6A3). The transport process
is active, deriving its free energy from the transmem-
brane concentration gradients of Na+ and Cl− that are
generated by Na+/K+ATPase and potassium chloride
symport [4, 5]. The major physiological role of the
DAT1 is the regulation of the extracellular dopamine by
means of rapid transport (reuptake) of dopamine back
into the dopaminergic presynaptic terminals.
Dopamine transport is a well-established target of
potent psychoactive compounds including cocaine,le distributed under the terms of the Creative Commons Attribution License
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removal of dopamine from extracellular space is a very
important physiological process [5–8]. Whereas cocaine
and methylphenidate are blockers of dopamine uptake,
amphetamine and methamphetamine can displace dopa-
mine as substrates of the dopamine transporter and can
trigger off release of dopamine from intracellular stores
(reviews: [6, 7]). Two of the most commonly used ADHD
medications, Ritalin™ (methylphenidate) and Adderall™
(combination of D- and L-amphetamine formulations) tar-
get dopamine transporters [7, 8].
DAT1/SLC6A3 gene encoding DAT1 comprises 15
exons spanning 60 kb on chromosome 5p15.32, encodes
620 amino acids with 12 putative transmembrane do-
mains and a large second extracellular loop with several
putative N-glycosylation sites that need to be glycosyl-
ated to transport dopamine (review: [5]).
The 3′-untranslated region (3′-UTR) DAT1/SLC6A3
polymorphism is a 40 bp VNTR (variable number tan-
dem repeat) repeated between 3–13 times with the 9
and 10-repeat allele being the most frequently found in
the human population. This polymorphism has been
linked to various disease phenotypes involving disturbed
regulation of dopaminergic neurotransmission [9].
DAT1 is primarily expressed in dopamine neurons.
DAT1 immunoreactivity is concentrated in somatoden-
dritic and terminal fields of mesencephalic dopamine
neurons with most pronounced immunoreactivity in
striatum and nucleus accumbens [10, 11]. Both of these
brain regions are potentially involved in the aetiology of
alcoholism and ADHD. However, a subpopulation of
dopaminergic neurons residing in ventral tegmental area
(VTA) projects also to various limbic structures includ-
ing anterior cingulate cortex (ACC) and other cortical
areas such as prefrontal cortex (PFC) [12]. Both ACC
and PFC are thought to play part in pathogenesis of
ADHD but may also be involved in, or affected by,
alcoholism.
In our previous studies we found associations between
ADHD, ANKK1 (DRD2) gene polymorphism and other
candidate genes [13–15] and an association between
the alcoholism and COMT gene [16]. In our study of
alcoholic patients, we found protective effect of the A
allele of BDNF Val66Met polymorphism (rs6265) on
colour vision deficiency induced by long-term exces-
sive alcohol intake and probably related to NMDAR
neurotoxicity [17].
In the present study we have been using well charac-
terized groups of Czech subjects similar to those used in
our previous studies [13–16]. We now report the results
of the analysis of the relationship between ADHD, alco-
holism and DAT1/SLC6A3 gene polymorphism in a sub-
set of a population sample numbering a total of 1312
persons.Materials and methods
Selection of ADHD patients and controls
The total of 471 mutually unrelated persons of Czech
ethnicity were included into ADHD study, 218 of them
children with ADHD (11 girls and 207 boys; for diagnos-
tic criteria vide infra) and 253 control subjects of corre-
sponding age (47 girls and 208 boys). All subjects were
apparent Caucasians. Children treated for ADHD (in
both outpatient and inpatient settings) in the Child
Ward of the Department of Psychiatry of the University
Hospital in Brno, in the Children’s Psychiatric Hospital
in Velká Bíteš, and in Department of Child Psychiatry,
1st Faculty of Medicine, Charles University, Prague were
included in the study group. Control group were stu-
dents collected as volunteers from elementary schools in
Brno (Brunn) and Praha (Prague).
Children aged 7 – 13 years were included in the study
(mean age ± SEM, 10.0 ± 1.7). In each case a written in-
formed consent was obtained from the child’s legal
guardian. Excluding criteria for participation in the study
for either of the groups were congenital genetic disor-
ders, epilepsy, mental retardation, schizophrenia, perva-
sive developmental disorders and serious medical illness.
In the group of ADHD-patients a detailed child-
psychiatric clinical examination was conducted with a
diagnostic assessment based on criteria of the 10th re-
vision of International Classification of Diseases – ICD
10 [18] as well as the DSM-IV [19].
The following questionnaires were used in the selection
and evaluation of the control subjects CTQ – Conners
Teacher Rating Scale [20] and CPQ – Children’s Parent
Questionnaire [21]. Only male participants who scored
both 9 points or less in CPQ questionnaire and 7 points
or less in CTQ questionnaire were included in the control
group. In addition, all control subjects were examined
by a qualified psychiatrist who administered a struc-
tured questionnaire based on criteria specified in DSM-
IV [19]. Thus any individuals significantly affected by
ADHD or any other mental disease would have been
eliminated from the group.
Evaluation of ADHD patients
We used the Shape Discrimination Test (TDT, Test dis-
kriminácie tvaru; [22]) for assessment of attention. The
test is based on determining the level of accuracy and
speed while differentiating among various shapes in a
given template. It requires constant mental focus on a
monotonous task, therefore, the test is considered as
suitable for evaluating attention. The test makes it pos-
sible to rate two criteria of achievement – speed (TDTr)
and accuracy (TDTp). The results were corrected for
age, gender and the level/type of education to date and
standardized according to the test manual. Using a
simple algorithm, also specified in the test manual, the
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deficit group.
Impulsivity was tested by the TE-NA-ZO test (Test of
finding of familiar figures, Test nachádzania známych
obrázkov; [23]). This test is based on a theoretical model
of cognitive style, represented by two components – im-
pulsivity (imp) and efficiency (ef ). Both imp and ef are
measured on a scale of 1–10 points. Scores 1–2 repre-
sent very high ef and very low imp (with a significant
amount of thoughtful decision making), scores up to 4
would still be indicative of high ef and low imp but 5–6
points are in the region of ambivalence. Scores above 7
would mean low ef and high imp with 9–10 indicating
the low and high extremes on both scales (efficiency and
impulsivity, respectively).
In addition we used four tests from the neuropsycho-
logical battery for psychological assessment of the Neu-
robehavioral Evaluation System (NES2) [24]: Finger
Tapping, Hand-Eye Coordination, Visual Digit Span and
Switching Attention. Finger Tapping evaluates motor
speed during a given time interval (30 s in this study).
The test is done separately on dominant and non-
dominant hand as well as on both (alternating) hands.
Hand-Eye Coordination test evaluates visual-motor co-
ordination. The specific task is to use a joystick and try
to keep the cursor on the monitor pointed to a dot mov-
ing at a constant speed along a sinusoid curve. Visual
Digit Span evaluates short-term memory and attention.
The proband is required to recall a row of displayed
numbers, in a manner similar to a subtest used in the
Wechsler Intelligence Scale. Switching Attention Test
is used to assess selective attention. It quantifies the
reaction to changes in the direction of an arrow dis-
played on the monitor; both the number of misses (dir)
and the reaction time (RT) are measured and included
in the evaluation.
Collection of DNA samples from ADHD patients and
control subjects
Samples of buccal tissues were collected using Flocked
Swabs (Copan, Italy) after the diagnosis was established.
DNA from swabs was isolated by using the UltraClean
Tissue DNA (MoBio, USA) commercial kit.
Alcoholic patients and controls
Alcohol dependent subjects were recruited from General
University Hospital in Prague, and several psychiatric
hospitals (Jihlava, Červený Dvůr, Lojovice, and Prague).
In total, 441 alcohol-dependent subjects (302 males and
139 females) were diagnosed to be alcohol-dependent
(mean age ± SEM, 45.0 ± 8.7 years). The diagnosis of al-
cohol dependence was based on a clinical assessment ac-
cording to DSM-IV criteria [19], the self-administered
Michigan Alcoholism Screening Test (MAST) [25], andthe CAGE questionnaire [26]. Responses to the CAGE
questionnaire are scored 0 for “no” and 1 for “yes” de-
signed so that higher scores indicate higher probability
of problem drinking. A total score of 2 or greater is con-
sidered a clinically significant indicator of alcohol depend-
ence. Additionally, all alcoholic patients were subjected
to detailed questioning as to the occurrence of delirium
tremens, evidence of alcohol-related problems with po-
lice, convictions for driving under the influence of alco-
hol, presence of social instability and tobacco smoking.
The control group comprised 400 mentally healthy
subjects (150 males and 250 females) who declared
themselves free of tobacco smoking, alcohol drinking
and illegal drug use (mean age ± SEM, 43.3 ± 8.7 years).
As an additional safeguard, all subjects were examined
by a structured questionnaire based on criteria specified
in DSM-IV [19]. This would have detected and elimi-
nated any person with a previously undeclared addiction
(whether to alcohol, nicotine or any other drug of abuse)
as well as anybody with a significant mental illness. The
control subjects were recruited from the same area as
the case group (Somatic and Transfusion Departments
of General University Hospital in Prague, Transfusion
Department of University Hospital Brno, Czech military
personnel, universities, manufacturing industry, National
Theatre Brno etc.). Control group was screened for alco-
holism using the same MAST and CAGE questionnaires
as in the case of alcoholic patients.
Collection of samples from alcoholic patients and controls
Samples of venous blood (containing EDTA to prevent
coagulation) were collected from all of the alcoholic and
control subjects. DNA was extracted from 200 μL of
whole blood using the UltraClean Blood DNA Isolation
Kit (Mobio, USA).
DNA analysis
The detection of 40-bp VNTR polymorphism of DAT1
gene was performed using a method described by Shino-
hara et al. [27]. PCR reaction contained: 5 ng of DNA,
Kapa2G Fast ready Mix (Kapa Biosystems), and 100 nM
primers 5′- tgt ggt gta ggg aac ggc ctg ag - 3′ and 5′- ctt
cct gga ggt cac ggc tca agg - 3′. Amplification was re-
vealed in thermal cycler Techne Touchgene Gradient.
After initial denaturation for 2 min at 94 °C, DNA was
amplified in free steps: denaturation for 30 s at 94 °C,
annealing for 20 s at 66 °C, and extension for 20 s at
72 °C. Final extension of 5 min at 72 °C was used. For
the detection of PCR fragments, gel electrophoresis on
2 % agarose gel EliPhore (ELISABETH PHARMACON,
Czech Republic) stained by ethidium bromide was used.
We detected 440 bp fragment (9 repeat allele), 480 bp
fragment (10 repeat allele), and 520 bp fragment (11
repeat allele).
Šerý et al. Behavioral and Brain Functions  (2015) 11:21 Page 4 of 8Statistical analyses
CSS Statistica Software (StatSoft, USA) was used for most
of the statistical evaluations. Contingency tables were con-
structed from the genotyping data. The chi-square test
was used for the comparison of genotype frequencies in
the groups; Fisher’s exact test was used for the allelic fre-
quencies comparison. The statistical difference between
genotype frequencies in ADHD group was calculated
using Fisher’s exact test by R software [28]; this test was
chosen because it could handle the absence (zero number)
of atypical genotypes in the control group. Subtypes with
different cognitive performance profiles were identified by
Quick Cluster (k-means) method. The statistical signifi-
cance of the differences among the subtypes of subjects
based on their performance in TDT, TE-NA-ZO and
NES2 tests was determined using Mann–Whitney U Test.
In silico analysis
We have performed a guided computer analysis of DAT1
gene by miRBase software [29]. VNTR part of DAT1




Genotyping was successful in all 471 ADHD patients
and controls (Table 1). In addition to the common 9/9,
9/10, and 10/10 genotypes we have also found rare geno-
types 8/10 (one boy), 7/10 (two boys) and 10/11 (three
boys). These rare genotypes have been found only in
ADHD boys and have been seen neither in ADHD girls
nor in any of the controls. Genotype distribution of 40-bp
VNTR polymorphism between ADHD and controls was
found to be significantly different using Fisher’s exact test
(P < 0.01). The 9/9 genotype appeared to reduce the risk
of ADHD about 0.4-fold (Odds Ratio = 0.3929; 95 % CI of
OR = 0.1521 till 1.0149, Risk Ratio = 0.4096; 95 % CI of
OR = 0.1644 till 1.0206, p < 0.04). We also detected a dif-
ference in the rare genotypes frequency between ADHD
and controls (p < 0.02). There was no significant difference
in 10/10 genotype frequency between ADHD patients and
controls (p = 0.2).
We have not found an association between 10-repeat
allele and divided subgroups of ADHD subjectsTable 1 Genotype distribution of 40-bp VNTR polymorphism in
ADHD and controls
Genotype 9/9 9/10 10/10 Atypical/rare
genotypes
Total p
ADHD 6 81 125 6 218
0,0079
controls 17 101 135 0 253
The statistical difference between genotype frequencies was calculated using
Fisher’s exact testcharacterized by very high impulsivity or high inatten-
tion. We have not found any association between high-
scored ADHD subjects and low-scored ADHD subjects
in neuropsychological tests and the 10-repeat allele.
Alcoholism
Genotypes were analyzed in all 841 alcoholics and con-
trols (Table 2). Rare genotypes 8/8, 8/10 and 8/11 of
VNTR polymorphism of DAT1 gene were found in alco-
holic patients and controls in similar numbers. Rare
genotype 9/11 was found in male controls only. When
we compared genotype frequencies between alcoholics
and control subjects, we have not observed any statisti-
cally significant difference whether we analysed the
group as a whole or separately as male and female
groups. When we compared DAT1 genotypes and al-
leles with data from personal histories of the alcoholic
patients, we have not been able to find any statistically
significant relationships between DAT1/SLC6A3 poly-
morphism and the occurrence of delirium tremens,
evidence of problems with police, convictions for the
driving a motor vehicle under the influence of alcohol,
social instability and tobacco smoking.
In silico analysis
Using miRBase software [29] we found in VNTR part of
DAT1 gene that is transcribed as part of mRNA the fol-
lowing miRNA binding regions: mir-1972, miR-30b-5p,
miR-1301 and miR-6070.
Discussion
ADHD: General considerations and possible role of
changes in DAT1/SLC6A3
Patients with ADHD are known to have morphological
abnormalities (mainly decreased size) in the cerebrum.
Furthermore, the dorsolateral prefrontal cortex (DLPFC),
anterior cingulate cortex (ACC) as well as their connec-
tions with striatal and parietal cortical regions appear to
be hypoactive [30] (reviews: [31–33]. These regions and
pathways are thought to be important in the mecha-
nisms of maintaining and shifting attention as well as
processing and filtering sensory input and, therefore,
would seem to be critical in the aetiology of ADHD;
interestingly, methylphenidate normalizes the hypoac-
tivities observed in ADHD (reviews: [34, 35]). As the
primary target of methylphenidate is dopamine trans-
port including the dopamine transporter DAT1 [1, 6–8]
changes in dopamine transport (perhaps involving altered
expression of DAT1) would seem to be the most probable
culprit in the development of ADHD.
It has been shown that distinct variations in DAT1/
SLC6A3 are associated with altered functions of brain
regions involved in ADHD [36] and molecular genetic
studies have focused on DAT1/SLC6A3 as one of the
Table 2 Genotype distribution of 40-bp VNTR polymorphism of DAT1 in alcoholics and controls
Genotype 9/9 9/10 10/10 9/11 Atypical/rare genotypes Total Χ2 p
controls 17 141 232 3 7 400
3,69 0,449
alcoholics 22 158 252 0 9 441
Male controls 7 50 85 3 5 150
7,18 0,127
Male alcoholics 18 106 172 0 6 302
Female controls 10 91 147 0 2 250
1,64 0,65
Female alcoholics 4 52 80 0 3 139
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lationship between VNTR polymorphism of DAT1/
SLC6A3 gene and ADHD, as well as the relationship be-
tween this polymorphism and alcoholism, have been
previously studied (reviews: [3, 38, 39]) and, further-
more, meta-analysis of the influence of VNTR poly-
morphism of DAT1/SLC6A3 gene on ADHD indicated a
statistically significant relationship (OR = 1.12, 95 % CI:
1.00-1.27) [40]. Interestingly, chronic exposure of mice
to alcohol has been shown to lead to epigenetic modifi-
cation of dopamine transport resulting in an ADHD-like
phenotype in the offspring [41]. Translated to the hu-
man condition, this could provide a link between inher-
ited predisposition to alcoholism and ADHD.
The above considerations might appear less conclusive
in the context of larger genome wide association studies
(GWAS), particularly after meta-analysis [42]; see also
critical comments in a more recent review [43]. Authors
of the meta-analytical study [41], however, pointed out
that GWAS samples may have been hurt by ethnic and
cultural heterogeneity and called for additional collabora-
tive efforts in collecting and analysing relevant ADHD
genetic data. The present data have been obtained from a
sample of a distinct and relatively homogenous population
thought to be representative of the European Caucasians
[44]; the sample may have been also less heterogeneous
than those used in GWAS studies, particularly in terms of
factors such as food habits or life style in general (for more
detailed discussion see [42]).
Polymorphisms in 3′-UTR of VNTR in DAT1/SLC6A3 gene
and ADHD
We have detected significantly different DAT1/SLC6A3
genotype frequencies distribution between ADHD chil-
dren and controls. Allele 10 has not been shown to be a
“risk” allele for ADHD, as previously indicated by meta-
analysis [39]. Additionally, a meta-analytical survey of
human single photon emission computed tomography
studies yielded no evidence of any significant association
between polymorphisms of the VNTR in DAT1/SLC6A3
gene and individual variations in DAT1 availability in
the human striatum [45]. We have, however, identified
rare genotypes 8/10, 7/10 and 10/11 as “risk” - (p < 0.01)
while the 9/9 genotype turned out to be protective. It isinteresting to note that rare genotypes 8/10, 7/10 and
10/11 were identified in only six ADHD boys while in
other 1306 persons (including alcoholic patients and
controls) these genotypes were completely absent. The
results of VanNess et al. [9] indicated that first 800 bp of
the DAT1 3′UTR region was associated with a decreased
DAT1 transcription, mRNA stability and translation. The
presence of 10-repeat allele resulted in the DAT1 bind-
ing site density elevated by approximately 50 % com-
pared to the 9-repeat allele. Fuke et al. [46] suggested
that the 10-repeat allele is related to a greater gene ex-
pression. The 10/10 genotype has been associated with
increased dopamine concentration in the CSF, lower IQ,
several neuropsychological and neurophysiological func-
tions (review: [47]). An interesting view on DAT1 in-
volvement in ADHD and other mental disorders put
forward by Kanno and Ishiura [48]. They found that
HESR family members had inhibitory effect on DAT
gene expression depending on the number of repeats in
the VNTR domain. The HESR family genes HESR1,
HESR2 and HESR3 were identified as the hairy/enhancer
split-type basic helix-loop-helix genes. These genes have
been shown to be direct transcriptional targets of the
NOTCH signalling pathway that is linked to neurodeve-
lopment. HESR1 and HESR2 inhibit DAT1 expression
depending on the VNTR allele by 25–50 %. The same
authors reported that the presence of androgen receptor
influenced inhibition of DAT1 by HESR1 and HESR2
depending on DAT1 VNTR polymorphism. Allele 9 de-
crease and 10 allele increase DAT1 expression in the
presence of androgen receptor [49]. HESR does not
seem to have been recently investigated in clinical
studies of ADHD.
Non-coding RNA and possible involvement of epigenetics
in the DAT1/SLC6A3 polymorphisms in ADHD
An alternative explanation for the relationship between
DAT1 VNTR polymorphism and ADHD is related to the
regulation of gene expression by miRNA. Recent devel-
opments very much broadened our knowledge and un-
derstanding of the mechanisms necessary for orderly
gene expression (recent review: [43]). Each cell produces
large amounts of RNA and not all of this RNA serves as
a template for the production of proteins. Hitherto
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have been discovered and some of them have been identi-
fied as miRNA. The main role of miRNA seems to be to
specifically intervene in the mechanisms of gene expres-
sion [50]. These recently discovered ncRNA’s (including
specific miRNA’s) are now methodologically accessible to
targeted genetic studies in humans (review: [43]).
In the case of DAT1 it has been predicted that it is tar-
geted by 49 miRNAs identified in miRDB database [29].
Accordingly, we have performed a guided computer ana-
lysis of VNTR part of DAT1 gene that is transcribed as
part of mRNA. VNTR part of DAT1 from NCBI (Refer-
ence Sequence NM_001044.4) has been analysed by
miRBase software [29]. We have found the following
miRNA binding regions in VNTR part of DAT1 gene:
mir-1972, miR-30b-5p, miR-1301 and miR-6070. Mir-
1972 was cloned in acute lymphoblastic leukaemia but
its role is not known [51]. MiR-1301 mentioned in the
context of tumorogenesis, circulating leptin levels and
pre-eclampsia [52]. MiR-6070 has been identified by
Voellenkle et al. [53] as being expressed by endothelial
cells exposed to hypoxia. MiR-30b-5p may act as a sup-
pressor of cardiac hypertrophy [54]. These miRNAs
should be looked at as novel targets of the research on
ADHD because they could be involved in the regulation
of DAT1/SLC6A3 expression which would then be influ-
enced by the VNTR polymorphism identified in the
present study as associated with ADHD.
It has been shown that epigenetic mechanisms such as
the cytosine methylation can affect the formation of
ncRNA as well and, in turn, ncRNA affects methylation
of cytosine [55]. Cytosine methylation is affected by a
wide range of factors like age, gender, race, food, dietary
amount of vitamins B6 and B12, by stress and toxic sub-
stances (review: [42]). Given that the aetiology of ADHD
is complex, has a substantial environmental component
and involves significant comorbidity [30, 56–58], the role
of epigenetics in ADHD should be given much more at-
tention in future studies. In fact, Womersley et al. [59]
reported a relationship between unpredictable maternal
separation in early postnatal life and altered dopamin-
ergic system in spontaneously hypertensive rat i.e. in an
animal model of ADHD [60]. The altered dopaminergic
system was characterised by reduced presence of DAT1/
SLC6A3 on the cell surface and/or lower affinity of DAT
for dopamine; given that these changes were produced
by early postnatal events, it is very likely that epigenetic
mechanisms, including DNA methylation, were involved
(see [43] for a review).
3′-UTR VNTR polymorphism in DAT1/SLC6A3 gene and
alcoholism
Human neuroimaging studies have identified neuroadap-
tive changes in the brain in response to chronic alcoholconsumption. The relevant neural circuits are anchored
in midbrain areas and their dopaminergic and gluta-
matergic projections [61, 62] to other brain structures
commonly associated with addiction, such as the ventral
striatum, striatal-pallido-thalamic loops, and prefrontal
cortices [63]. DAT1/SLC6A3 has been previously recog-
nized as a candidate gene in the alcoholism pathogenesis
in striatum and other brain areas related to reward sys-
tem. The relationship between DAT1/SLC6A3 and alco-
holism may be complex and could involve additional
interactions with other genes. We haven’t been able to
find any clear association between DAT1/SLC6A3 VNTR
polymorphism and alcoholism (or any particular mani-
festations of it) in the population samples that we have
analysed and this is in agreement with a previous meta-
analytical study by van der Zwaluw [3]. It may imply that
the associations identified as statistically significant in
the current study are specifically related to ADHD.
Conclusion
We have identified significant differences between juven-
ile ADHD patients and corresponding controls in DAT1/
SLC6A3 gene encoding DAT1 dopamine transporter.
The differences were of a VNTR polymorphism type in
an untranslated region of the gene. Preliminary in silico
analysis indicated that the region is potentially rich in
miRNA’s binding sites. These miRNA’s may be of im-
portance in the regulation of DAT1 expression. The
present study has detected no significant differences be-
tween alcoholic patients and controls thus suggesting
that the studied variations of DAT1/SLC6A3 (and pos-
sible resulting changes in DAT1 expression) could be
more closely associated with ADHD than alcoholism.
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